Its in the draft agenda
Geraldine storton- Head of Quality management
- Intro and manufacturing
Siliviu Itescu- ceo
- pathophysiology, moa, potency.
Fred groseman - cmo
- efficacy and safety
guest presenters
Joanne kurtzberg - duke university, pediatric expert and co author of our studies published in bone marrow jounal.
- clinical perspective
Sally temple. director, cell therapy institute.
- Cell manufacfure and therapeutic application..
https://www.fda.gov/media/140999/download
FDA ODAC Meeting Material discussion analysis, page-301
-
- There are more pages in this discussion • 191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.3¢ |
Change
0.023(2.37%) |
Mkt cap ! $1.098B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 98.0¢ | 93.5¢ | $2.487M | 2.583M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 71235 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 157631 | 22 |
View Market Depth
| Last trade - 14.25pm 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |